期刊
CELL METABOLISM
卷 20, 期 2, 页码 201-203出版社
CELL PRESS
DOI: 10.1016/j.cmet.2014.07.016
关键词
-
资金
- NIDDK NIH HHS [R01 DK059579, P30 DK041301] Funding Source: Medline
The insulin-degrading enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer's disease susceptibility gene, though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
